John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 41,832 shares at $19.69 ($799K) on 2023-07-25, disclosed to the SEC on 2023-07-27.
Open-market sale of $799k KNSA by CHIEF MEDICAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.01 | 5,200 | $94K | 11.7% |
| 2 | $18.01 | 5,200 | $94K | 11.7% |
| 3 | $19.25 | 16,168 | $311K | 38.9% |
| 4 | $19.69 | 7,632 | $150K | 18.8% |
| 5 | $19.69 | 7,632 | $150K | 18.8% |
| Total | $19.10 avg | 41,832 |
| $799K |
| 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |